Hi Gg, Thanks for catching this. We will correct the error when we update the report to include outcomes of the consensus call. Kind regards, Emily From: Gnso-newgtld-wg <gnso-newgtld-wg-bounces@icann.org> on behalf of "Levine, Gertrude via Gnso-newgtld-wg" <gnso-newgtld-wg@icann.org> Reply to: "Levine, Gertrude" <glevine@nabp.pharmacy> Date: Tuesday, 5 January 2021 at 23:48 To: Jeff Neuman <jeff@jjnsolutions.com>, "Cheryl Langdon-Orr (cheryl@hovtek.com.au)" <cheryl@hovtek.com.au>, "gnso-newgtld-wg@icann.org" <gnso-newgtld-wg@icann.org> Subject: [Gnso-newgtld-wg] Minor error in SubPro report Hi Jeff and Cheryl, I have come across what appears to be a minor error in the SubPro final report. In the Summary of Outcomes on pages 267-268, Recommendation 9.1 references Specification 11 3(a)-(d) and includes footnote #295, which lists the relevant sections. However, the footnote lists what should be sections (a)-(d) as sections (e)-(f). The corresponding footnote in the body of the report on pages 37-38 lists the sections correctly. Best regards, Gg Gertrude “Gg” Levine Digital Health Manager 847/391-4497 [cid:image001.png@01D6E407.3FCF42E0]National Association of Boards of Pharmacy 1600 Feehanville Dr, Mount Prospect, IL 60056 www.nabp.pharmacy<http://www.nabp.pharmacy> | glevine@nabp.pharmacy<mailto:glevine@nabp.pharmacy> [cid:image002.png@01D6E407.3FCF42E0]<https://www.facebook.com/NABP1904/> [cid:image003.png@01D6E407.3FCF42E0]<https://twitter.com/nabp> [cid:image004.png@01D6E407.3FCF42E0]<https://www.linkedin.com/company/national-association-of-boards-of-pharmacy/> [cid:image005.png@01D6E407.3FCF42E0]<https://www.youtube.com/c/NationalAssociationofBoardsofPharmacy>